Our results confirm that inappropriately high levels of IL6 in MSCs of CS patients during cutaneous repair may represent an important pathogenic component of the inflammatory-related vascular and metabolic complications associated with glucocorticoid excess (Barahona et al., 2009). The gene discussed is IL6; the disease is Cowden syndrome 1.